Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2023-02-10 1:20 pm Purchase | 13G | Vera Therapeutics Inc. VERA | Kynam Capital Management LP | 1,409,098 5.1% | 1,409,098 (New Position) | View |
| 2023-02-09 12:39 pm Purchase | 13G | Vera Therapeutics Inc. VERA | FMR LLC | 4,148,646 15% | 1,003,444 (+31.90%) | View |
| 2023-02-03 7:07 pm Purchase | 13D | Vera Therapeutics Inc. VERA | Sofinnova Venture Partners X L.P. | 3,191,367 11.5% | 276,591 (+9.49%) | View |
| 2023-02-03 5:22 pm Unchanged | 13G | Vera Therapeutics Inc. VERA | Kleiner Perkins Caufield & Byers XVI LLC | 1,343,152 4.9% | 0 (Unchanged) | View |
| 2023-01-27 06:17 am Unchanged | 13G | Vera Therapeutics Inc. VERA | Ares Trading S.A. | 1,913,501 6.92% | 0 (Unchanged) | View |
| 2022-08-11 5:01 pm Purchase | 13D | Vera Therapeutics Inc. VERA | Carlyle Group Inc. CG | 2,970,156 11.1% | 2,970,156 (New Position) | View |
| 2022-04-07 4:39 pm Purchase | 13D | Vera Therapeutics Inc. VERA | Abingworth LLP | 2,970,156 11.1% | 9,925 (+0.34%) | View |
| 2022-04-05 07:36 am Purchase | 13D | Vera Therapeutics Inc. VERA | Longitude Capital Partners IV LLC | 3,439,852 12.7% | 343,258 (+11.09%) | View |
| 2022-02-24 4:30 pm Purchase | 13G | Vera Therapeutics Inc. VERA | RA CAPITAL MANAGEMENT L.P. | 2,000,000 7.5% | 2,000,000 (New Position) | View |
| 2022-02-14 06:30 am Purchase | 13G | Vera Therapeutics Inc. VERA | CITADEL ADVISORS LLC | 2,042,420 9.6% | 17,370 (+0.86%) | View |
| 2022-02-11 4:51 pm Purchase | 13G | Vera Therapeutics Inc. VERA | Kleiner Perkins Caufield & Byers XVI LLC | 1,343,152 6.4% | 1,343,152 (New Position) | View |
| 2022-02-09 10:01 am Purchase | 13G | Vera Therapeutics Inc. VERA | FMR LLC | 3,145,202 14.999% | 73,306 (+2.39%) | View |
| 2022-01-24 10:01 am Purchase | 13G | Vera Therapeutics Inc. VERA | Ares Trading S.A. | 1,913,501 8.99% | 1,913,501 (New Position) | View |
| 2021-06-10 11:37 am Purchase | 13G | Vera Therapeutics Inc. VERA | FMR LLC | 3,071,896 15.229% | 3,071,896 (New Position) | View |
| 2021-05-28 4:17 pm Purchase | 13G | Vera Therapeutics Inc. VERA | CITADEL ADVISORS LLC | 2,025,050 9.9% | 2,025,050 (New Position) | View |
| 2021-05-27 4:32 pm Purchase | 13D | Vera Therapeutics Inc. VERA | Longitude Capital Partners IV LLC | 3,096,594 15.1% | 3,096,594 (New Position) | View |
| 2021-05-24 1:46 pm Purchase | 13D | Vera Therapeutics Inc. VERA | Sofinnova Venture Partners X L.P. | 2,914,776 14.5% | 2,914,776 (New Position) | View |
| 2021-05-24 09:34 am Purchase | 13D | Vera Therapeutics Inc. VERA | Abingworth LLP | 2,960,231 14.6% | 2,960,231 (New Position) | View |